Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 8 | 2020 | 111 | 4.000 |
Why?
|
| Ataxia | 7 | 2020 | 43 | 3.880 |
Why?
|
| Tremor | 7 | 2020 | 65 | 3.830 |
Why?
|
| Fragile X Mental Retardation Protein | 5 | 2016 | 57 | 1.360 |
Why?
|
| Gait | 5 | 2020 | 363 | 1.310 |
Why?
|
| Accidental Falls | 3 | 2020 | 99 | 1.300 |
Why?
|
| Postural Balance | 3 | 2021 | 97 | 1.280 |
Why?
|
| Heterozygote | 4 | 2020 | 71 | 1.170 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2020 | 119 | 1.110 |
Why?
|
| Walking Speed | 2 | 2020 | 34 | 0.800 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 180 | 0.790 |
Why?
|
| Databases, Factual | 2 | 2021 | 300 | 0.770 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2020 | 2 | 0.670 |
Why?
|
| Nootropic Agents | 1 | 2020 | 8 | 0.670 |
Why?
|
| Movement Disorders | 2 | 2020 | 52 | 0.660 |
Why?
|
| Attention | 1 | 2020 | 96 | 0.660 |
Why?
|
| Huntington Disease | 1 | 2020 | 43 | 0.640 |
Why?
|
| Male | 16 | 2021 | 12453 | 0.630 |
Why?
|
| Phenotype | 3 | 2016 | 254 | 0.630 |
Why?
|
| Walking | 1 | 2020 | 207 | 0.600 |
Why?
|
| Female | 15 | 2021 | 12677 | 0.590 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 685 | 0.590 |
Why?
|
| Cyclodextrins | 1 | 2018 | 6 | 0.580 |
Why?
|
| Executive Function | 1 | 2018 | 93 | 0.570 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2018 | 11 | 0.570 |
Why?
|
| Humans | 14 | 2021 | 22848 | 0.470 |
Why?
|
| Middle Aged | 8 | 2020 | 7555 | 0.460 |
Why?
|
| Receptors, Estrogen | 5 | 1995 | 50 | 0.440 |
Why?
|
| Aged | 7 | 2020 | 7669 | 0.440 |
Why?
|
| Hyperkinesis | 1 | 2013 | 7 | 0.430 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 17 | 0.430 |
Why?
|
| Adolescent | 4 | 2021 | 1775 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2018 | 807 | 0.400 |
Why?
|
| Child | 3 | 2021 | 990 | 0.360 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 982 | 0.350 |
Why?
|
| Reference Values | 2 | 2021 | 152 | 0.340 |
Why?
|
| Walk Test | 2 | 2020 | 9 | 0.340 |
Why?
|
| Adult | 5 | 2021 | 6584 | 0.330 |
Why?
|
| Child, Preschool | 2 | 2021 | 489 | 0.310 |
Why?
|
| Biomechanical Phenomena | 3 | 2016 | 582 | 0.310 |
Why?
|
| Young Adult | 3 | 2021 | 1721 | 0.310 |
Why?
|
| Hippocampus | 4 | 1995 | 222 | 0.310 |
Why?
|
| Cognition | 2 | 2020 | 1104 | 0.190 |
Why?
|
| Parkinson Disease | 2 | 2020 | 556 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2020 | 500 | 0.180 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3062 | 0.170 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 15 | 0.170 |
Why?
|
| Glucosylceramidase | 1 | 2020 | 12 | 0.170 |
Why?
|
| Foot | 1 | 2020 | 34 | 0.170 |
Why?
|
| Arm | 1 | 2020 | 80 | 0.160 |
Why?
|
| Animals | 7 | 2016 | 3025 | 0.160 |
Why?
|
| Range of Motion, Articular | 2 | 2020 | 643 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2020 | 334 | 0.150 |
Why?
|
| Mutation | 1 | 2020 | 284 | 0.150 |
Why?
|
| Infusions, Spinal | 1 | 2018 | 5 | 0.140 |
Why?
|
| Motor Activity | 1 | 2020 | 239 | 0.140 |
Why?
|
| Spinal Puncture | 1 | 2018 | 23 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 4055 | 0.140 |
Why?
|
| Brain Tissue Transplantation | 2 | 1993 | 13 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2016 | 27 | 0.130 |
Why?
|
| Posture | 1 | 2016 | 54 | 0.130 |
Why?
|
| Time Factors | 1 | 2020 | 1220 | 0.130 |
Why?
|
| Computers | 1 | 2015 | 12 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 21 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 43 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2016 | 108 | 0.120 |
Why?
|
| Reaction Time | 1 | 2015 | 89 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 1993 | 118 | 0.120 |
Why?
|
| Animals, Newborn | 3 | 1993 | 34 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 63 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 210 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 1994 | 1 | 0.120 |
Why?
|
| Disability Evaluation | 1 | 2016 | 223 | 0.120 |
Why?
|
| Receptors, Progesterone | 1 | 1994 | 22 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 1 | 1994 | 11 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1994 | 20 | 0.120 |
Why?
|
| Arousal | 1 | 1994 | 42 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 1995 | 254 | 0.110 |
Why?
|
| Disease Progression | 1 | 2016 | 554 | 0.110 |
Why?
|
| Rats | 6 | 1995 | 554 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 42 | 0.110 |
Why?
|
| Cerebellar Diseases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Movement | 1 | 2013 | 95 | 0.100 |
Why?
|
| Neurons | 2 | 1995 | 259 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 539 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 947 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 2960 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2016 | 1621 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 977 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1995 | 283 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1993 | 20 | 0.050 |
Why?
|
| Estradiol | 2 | 1993 | 43 | 0.050 |
Why?
|
| Pregnancy | 2 | 1993 | 303 | 0.040 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 1 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 5 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 10 | 0.030 |
Why?
|
| Sex Differentiation | 1 | 1995 | 2 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 18 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1995 | 23 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 40 | 0.030 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1994 | 3 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1994 | 4 | 0.030 |
Why?
|
| Gene Expression | 1 | 1995 | 166 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 25 | 0.030 |
Why?
|
| Cytosol | 2 | 1992 | 41 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 1993 | 4 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1994 | 133 | 0.030 |
Why?
|
| Preoptic Area | 1 | 1993 | 4 | 0.030 |
Why?
|
| Aging | 2 | 1993 | 1290 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 215 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1993 | 71 | 0.030 |
Why?
|
| Age Factors | 1 | 1995 | 657 | 0.030 |
Why?
|
| Calcium | 1 | 1995 | 333 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 905 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1990 | 1 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 1990 | 2 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 1990 | 2 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 4 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1990 | 75 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 145 | 0.020 |
Why?
|
| Sex Factors | 1 | 1990 | 381 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 1995 | 1 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1995 | 17 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 17 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 390 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 238 | 0.010 |
Why?
|